United States - English - NLM (National Library of Medicine)

alvogen inc. - pyrimethamine (unii: z3614qox8w) (pyrimethamine - unii:z3614qox8w) - treatment of toxoplasmosis: pyrimethamine is indicated for the treatment of toxoplasmosis when used conjointly with a sulfonamide, since synergism exists with this combination. use of pyrimethamine is contraindicated in patients with known hypersensitivity to pyrimethamine or to any component of the formulation. use of the drug is also contraindicated in patients with documented megaloblastic anemia due to folate deficiency.

United States - English - NLM (National Library of Medicine)

fera pharmaceuticals, llc - pyrimethamine (unii: z3614qox8w) (pyrimethamine - unii:z3614qox8w) - treatment of toxoplasmosis: pyrimethamine is indicated for the treatment of toxoplasmosis when used conjointly with a sulfonamide, since synergism exists with this combination. use of pyrimethamine is contraindicated in patients with known hypersensitivity to pyrimethamine or to any component of the formulation. use of the drug is also contraindicated in patients with documented megaloblastic anemia due to folate deficiency.

United States - English - NLM (National Library of Medicine)

teva pharmaceuticals, inc. - pyrimethamine (unii: z3614qox8w) (pyrimethamine - unii:z3614qox8w) - treatment of toxoplasmosis : pyrimethamine tablets are indicated for the treatment of toxoplasmosis when used conjointly with a sulfonamide, since synergism exists with this combination. use of pyrimethamine tablets are contraindicated in patients with known hypersensitivity to pyrimethamine or to any component of the formulation. use of the drug is also contraindicated in patients with documented megaloblastic anemia due to folate deficiency.

United States - English - NLM (National Library of Medicine)

aurobindo pharma limited - pyrimethamine (unii: z3614qox8w) (pyrimethamine - unii:z3614qox8w) - treatment of toxoplasmosis: pyrimethamine tablets are indicated for the treatment of toxoplasmosis when used conjointly with a sulfonamide, since synergism exists with this combination. use of pyrimethamine tablets are contraindicated in patients with known hypersensitivity to pyrimethamine or to any component of the formulation. use of the drug is also contraindicated in patients with documented megaloblastic anemia due to folate deficiency.

United States - English - NLM (National Library of Medicine)

vyera pharmaceuticals llc - pyrimethamine (unii: z3614qox8w) (pyrimethamine - unii:z3614qox8w) - pyrimethamine 25 mg - treatment of toxoplasmosis: daraprim is indicated for the treatment of toxoplasmosis when used conjointly with a sulfonamide, since synergism exists with this combination. use of daraprim is contraindicated in patients with known hypersensitivity to pyrimethamine or to any component of the formulation. use of the drug is also contraindicated in patients with documented megaloblastic anemia due to folate deficiency.

Kenya - English - Pharmacy and Poisons Board

guilin pharmaceutical co. ltd. no 43 qilidian road guilin 541004guangxiprchina - sulfadoxine & pyrimethamine - tablet - sulfadoxine 500mg & pyrimethamine 25mg - antimalarial antiprotozoals: combinations of

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

jurox pty limited - sulfadoxine - unknown - sulfadoxine sulfanyl active 0.0 - active constituent

Tanzania - English - Tanzania Medicinces & Medical Devices Authority

shanghai fosun pharmaceutical development co., ltd, china - sulfadoxine/pyrimethamine/amodiaquine (as hydrochloride) - dispersible tablets - 250/12.5/76.5

Tanzania - English - Tanzania Medicinces & Medical Devices Authority

remedica ltd, cyprus - pyrimethamine , sulfadoxine - tablets - 25 mg + 500 mg

Kenya - English - Pharmacy and Poisons Board

laboratory & allied ltd p.o box 42875 gpo 00100 nairobi kenya - sulfadoxine and pyrimethamine tablets - tablet - sulfadoxine 500mg and pyrimethamine 25 mg per… - antimalarial antiprotozoals: diaminopyrimidines